scholarly journals Visual Clustering of Transcriptomic Data from Primary and Metastatic Tumors – Dependencies and Novel Pitfalls

2021 ◽  
Author(s):  
André Marquardt ◽  
Philip Kollmannsberger ◽  
Markus Krebs ◽  
Markus Knott ◽  
Antonio Giovanni Solimando ◽  
...  

1.AbstractPersonalized Oncology is a rapidly evolving area and offers cancer patients therapy options more specific than ever. Yet, there is still a lack of understanding regarding transcriptomic similarities or differences of metastases and corresponding primary sites. Approaching this question, we used two different unsupervised dimension reduction methods – t-SNE and UMAP – on three different metastases datasets – prostate cancer, neuroendocrine prostate cancer, and skin cutaneous melanoma – including 682 different samples, with three different underlying data transformations – unprocessed FPKM values, log10 transformed FPKM values, and log10+1 transformed FPKM values – to visualize potential underlying clusters. The approaches resulted in formation of different clusters that were independent of respective resection sites. Additionally, data transformation critically affected cluster formation in most cases. Of note, our study revealed no tight link between the metastasis resection site and specific transcriptomic features. Instead, our analysis demonstrates the dependency of cluster formation on the underlying data transformation and the dimension reduction method applied. These observations propose data transformation as another key element in the interpretation of visual clustering approaches apart from well-known determinants such as initialization and parameters. Furthermore, the results show the need for further evaluation of underlying data alterations based on the biological question and subsequently used methods and applications.

2021 ◽  
Vol 18 ◽  
pp. 148-151
Author(s):  
Jinqing Shen ◽  
Zhongxiao Li ◽  
Xiaodong Zhuang

Data dimension reduction is an important method to overcome dimension disaster and obtain as much valuable information as possible. Speech signal is a kind of non-stationary random signal with high redundancy, and proper dimension reduction methods are needed to extract and analyze the signal features efficiently in speech signal processing. Studies have shown that manifold structure exists in high-dimensional data. Manifold dimension reduction method aiming at discovering the intrinsic geometric structure of data may be more effective in dealing with practical problems. This paper studies a data dimension reduction method based on manifold learning and applies it to the analysis of vowel signals.


Author(s):  
CHEONG HEE PARK

Dimension reduction has been applied in various areas of pattern recognition and data mining. While a traditional dimension reduction method, Principal Component Analysis (PCA) finds projective directions to maximize the global scatter in data, Locality Preserving Projection (LPP) pursues linear dimension reduction to minimize the local scatter. However, the discriminative power by either global or local scatter optimization is not guaranteed to be effective for classification. A recently proposed method, Unsupervised Discriminant Projection (UDP) aims to minimize the local scatter among near points and maximize the global scatter of distant points at the same time. Although its performance has been proven to be comparable to other dimension reduction methods, PCA preprocessing step due to the singularity of global and local scatter matrices may degrade the performance of UDP. In this paper, we propose several algorithms to improve the performances of UDP greatly. An improved algorithm for UDP is presented which applies the Generalized Singular Value Decomposition (GSVD) to overcome singularities of scatter matrices in UDP. Two-dimensional UDP and nonlinear extension of UDP are also proposed. Extensive experimental results demonstrate superiority of the proposed algorithms.


Cancers ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 692
Author(s):  
Roosa Kaarijärvi ◽  
Heidi Kaljunen ◽  
Kirsi Ketola

Neuroendocrine plasticity and treatment-induced neuroendocrine phenotypes have recently been proposed as important resistance mechanisms underlying prostate cancer progression. Treatment-induced neuroendocrine prostate cancer (t-NEPC) is highly aggressive subtype of castration-resistant prostate cancer which develops for one fifth of patients under prolonged androgen deprivation. In recent years, understanding of molecular features and phenotypic changes in neuroendocrine plasticity has been grown. However, there are still fundamental questions to be answered in this emerging research field, for example, why and how do the prostate cancer treatment-resistant cells acquire neuron-like phenotype. The advantages of the phenotypic change and the role of tumor microenvironment in controlling cellular plasticity and in the emergence of treatment-resistant aggressive forms of prostate cancer is mostly unknown. Here, we discuss the molecular and functional links between neurodevelopmental processes and treatment-induced neuroendocrine plasticity in prostate cancer progression and treatment resistance. We provide an overview of the emergence of neurite-like cells in neuroendocrine prostate cancer cells and whether the reported t-NEPC pathways and proteins relate to neurodevelopmental processes like neurogenesis and axonogenesis during the development of treatment resistance. We also discuss emerging novel therapeutic targets modulating neuroendocrine plasticity.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Siyuan Cheng ◽  
Shu Yang ◽  
Yingli Shi ◽  
Runhua Shi ◽  
Yunshin Yeh ◽  
...  

AbstractHOX gene-encoded homeobox proteins control body patterning during embryonic development; the specific expression pattern of HOX genes may correspond to tissue identity. In this study, using RNAseq data of 1019 human cancer cell lines that originated from 24 different anatomic sites, we established HOX codes for various types of tissues. We applied these HOX codes to the transcriptomic profiles of prostate cancer (PCa) samples and found that the majority of prostate adenocarcinoma (AdPCa) samples sustained a prostate-specific HOX code whereas the majority of neuroendocrine prostate cancer (NEPCa) samples did not, which reflects the anaplastic nature of NEPCa. Also, our analysis showed that the NEPCa samples did not correlate well with the HOX codes of any other tissue types, indicating that NEPCa tumors lose their prostate identities but do not gain new tissue identities. Additionally, using immunohistochemical staining, we evaluated the prostatic expression of HOXB13, the most prominently changed HOX gene in NEPCa. We found that HOXB13 was expressed in both benign prostatic tissues and AdPCa but its expression was reduced or lost in NEPCa. Furthermore, we treated PCa cells with all trans retinoic acid (ATRA) and found that the reduced HOXB13 expression can be reverted. This suggests that ATRA is a potential therapeutic agent for the treatment of NEPCa tumors by reversing them to a more treatable AdPCa.


2008 ◽  
Vol 283 (28) ◽  
pp. 19872
Author(s):  
Florian Gackière ◽  
Gabriel Bidaux ◽  
Philippe Delcourt ◽  
Fabien Van Coppenolle ◽  
Maria Katsogiannou ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Divya Bhagirath ◽  
Michael Liston ◽  
Theresa Akoto ◽  
Byron Lui ◽  
Barbara A. Bensing ◽  
...  

AbstractNeuroendocrine prostate cancer (NEPC), a highly aggressive variant of castration-resistant prostate cancer (CRPC), often emerges upon treatment with androgen pathway inhibitors, via neuroendocrine differentiation. Currently, NEPC diagnosis is challenging as available markers are not sufficiently specific. Our objective was to identify novel, extracellular vesicles (EV)-based biomarkers for diagnosing NEPC. Towards this, we performed small RNA next generation sequencing in serum EVs isolated from a cohort of CRPC patients with adenocarcinoma characteristics (CRPC-Adeno) vs CRPC-NE and identified significant dysregulation of 182 known and 4 novel miRNAs. We employed machine learning algorithms to develop an ‘EV-miRNA classifier’ that could robustly stratify ‘CRPC-NE’ from ‘CRPC-Adeno’. Examination of protein repertoire of exosomes from NEPC cellular models by mass spectrometry identified thrombospondin 1 (TSP1) as a specific biomarker. In view of our results, we propose that a miRNA panel and TSP1 can be used as novel, non-invasive tools to identify NEPC and guide treatment decisions. In conclusion, our study identifies for the first time, novel non-invasive exosomal/extracellular vesicle based biomarkers for detecting neuroendocrine differentiation in advanced castration resistant prostate cancer patients with important translational implications in clinical management of these patients that is currently extremely challenging.


Sign in / Sign up

Export Citation Format

Share Document